Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice.
Aguiar J, Fernández J, Aguilar A, Mendoza Y, Vázquez M, Suárez J, Berlanga J, Cruz S, Guillén G, Herrera L, Velázquez L, Santos N, Merino N. Aguiar J, et al. Among authors: guillen g. Neurosci Lett. 2006 Jan 16;392(3):202-6. doi: 10.1016/j.neulet.2005.09.020. Epub 2005 Oct 3. Neurosci Lett. 2006. PMID: 16203087
Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: a road map for discovering new antigens.
Gil J, Betancourt LZ, Sardiñas G, Yero D, Niebla O, Delgado M, García D, Pajón R, Sánchez A, González LJ, Padrón G, Campa C, Sotolongo F, Barberó R, Guillén G, Herrera L, Besada V. Gil J, et al. Among authors: guillen g. Hum Vaccin. 2009 May;5(5):347-56. doi: 10.4161/hv.5.5.7367. Epub 2009 May 8. Hum Vaccin. 2009. PMID: 19377283
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
Marcos E, Lazo L, Gil L, Izquierdo A, Suzarte E, Valdés I, Blanco A, Ancizar J, Alba JS, Pérez Yde L, Cobas K, Romero Y, Guillén G, Guzmán MG, Hermida L. Marcos E, et al. Among authors: guillen g. Immunol Lett. 2016 Aug;176:51-6. doi: 10.1016/j.imlet.2016.05.014. Epub 2016 May 24. Immunol Lett. 2016. PMID: 27233365
Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac.
Junco JA, Rodríguez R, Fuentes F, Baladrón I, Castro MD, Calzada L, Valenzuela C, Bover E, Pimentel E, Basulto R, Arteaga N, Cid-Arregui A, Sariol F, González L, Porres-Fong L, Medina M, Rodríguez A, Garay AH, Reyes O, López M, de Quesada L, Alvarez A, Martínez C, Marrero M, Molero G, Guerra A, Rosales P, Capote C, Acosta S, Vela I, Arzuaga L, Campal A, Ruiz E, Rubio E, Cedeño P, Sánchez MC, Cardoso P, Morán R, Fernández Y, Campos M, Touduri H, Bacardi D, Feria I, Ramirez A, Cosme K, Saura PL, Quintana M, Muzio V, Bringas R, Ayala M, Mendoza M, Fernández LE, Carr A, Herrera L, Guillén G. Junco JA, et al. Among authors: guillen g. Front Oncol. 2019 Feb 25;9:49. doi: 10.3389/fonc.2019.00049. eCollection 2019. Front Oncol. 2019. PMID: 30859088 Free PMC article.
246 results